Evidence map›Paper›PMID 42678952›Full record

ArticlePloS one2026

Characterization of diabetic peripheral neuropathy in a high-fat diet mouse model.

Guillaume Rastoldo, Alexis Chirpaz, Sarrah Tréport, Anne-Yael Gamin, Ali K Jaafar, Aurélie Paulo-Ramos, Thomas Sandaye, Katy Thouvenot, Matthieu Bringart, Marie-Paule Gonthier and 2 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guillaume RastoldoUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.ORCID https://orcid.org/0000-0001-9892-484X
Alexis ChirpazUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.
Sarrah TréportUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.
Anne-Yael GaminUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.ORCID https://orcid.org/0009-0007-4533-8215
Ali K JaafarUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.
Aurélie Paulo-RamosUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.
Thomas SandayeUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.
Katy ThouvenotUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.
Matthieu BringartUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.
Marie-Paule GonthierUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.
Gilles C LambertUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.
Steeve BouraneUMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Université de La Réunion, INSERM, Saint-Pierre, La Réunion.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic peripheral neuropathy (DPN) is characterized by progressive and symmetrical sensory alterations and constitutes one of the earliest and main complications of diabetes. Several mouse models have been developed to mimic the pathogenesis of DPN with some discrepancies to fully recapitulate the human disease. In the present study, we aimed to characterize the onset and progression of peripheral neuropathy in mice fed with 45% kcal High Fat Diet (HFD) for 16 weeks. Our data show that mice fed with this diet developed obesity, dyslipidemia, hyperglycemia, impaired glucose tolerance and insulin resistance. Using sensory tests, we found that HFD-fed mice developed mechanical hypoalgesia and thermal hyperalgesia starting after 12 weeks of diet. Our analysis of glabrous foot skin innervation revealed a decrease in intraepidermal nerve fiber density (IENFD) associated with a significant reduction of nociceptive Schwann cells (nSCs) in neuropathic mice after 16 weeks of HFD. Overall, this study shows that mice fed with a 45% kcal HFD recapitulate the main metabolic, behavioral and anatomical changes generally observed in patients with DPN and represent a reliable model to study the pathogenesis of the disease.

Indexed as

Diabetic NeuropathiesDiet, High-FatAnimalsDisease Models, AnimalHyperalgesiaInsulin ResistanceMaleMiceMice, Inbred C57BLNerve FibersObesitySchwann Cells

Identifiers

PMID42678952
PMCPMC13533349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.